Dariusz Dudek Selected Research

Everolimus

7/2019	Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial.
1/2018	Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial).
11/2016	Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
9/2016	A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
2/2016	A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
2/2016	Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis.
7/2015	Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
1/2015	A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
10/2013	Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
1/2012	Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dariusz Dudek Research Topics

Disease

129	ST Elevation Myocardial Infarction 08/2021 - 01/2004
122	Myocardial Infarction 01/2022 - 01/2002
68	Thrombosis (Thrombus) 01/2021 - 01/2005
59	Hemorrhage 09/2022 - 01/2003
40	Acute Coronary Syndrome 01/2022 - 03/2003
38	Stroke (Strokes) 03/2022 - 01/2003
36	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 03/2003
33	Infarction (Infarctions) 09/2018 - 01/2002
27	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2002
25	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 08/2009
14	Cardiogenic Shock 10/2021 - 01/2004
12	Ischemia 12/2015 - 03/2003
11	Hypertension (High Blood Pressure) 11/2020 - 01/2011
11	Death (Near-Death Experience) 01/2019 - 02/2008
10	Diabetes Mellitus 09/2022 - 04/2009
10	Stable Angina 02/2022 - 05/2003
10	Non-ST Elevated Myocardial Infarction 01/2019 - 02/2009
9	Coronary Stenosis (Coronary Artery Stenosis) 09/2021 - 03/2003
9	Heart Failure 12/2020 - 09/2004
8	Atherosclerotic Plaque (Atheroma) 06/2020 - 09/2008
8	Chest Pain (Chest Pains) 01/2017 - 11/2005
7	Pathologic Constriction (Stenosis) 01/2022 - 01/2003
6	Chronic Renal Insufficiency 09/2022 - 09/2011
6	Shock 09/2021 - 01/2004
6	Rupture 06/2021 - 09/2008
6	Neointima 03/2018 - 11/2002
6	Coronary Disease (Coronary Heart Disease) 01/2017 - 01/2003
6	Renal Insufficiency (Renal Failure) 01/2017 - 06/2007
6	Unstable Angina 07/2015 - 03/2003
5	COVID-19 08/2021 - 11/2020
5	Chronic Obstructive Pulmonary Disease (COPD) 09/2018 - 04/2009
5	Ischemic Stroke 03/2013 - 02/2008
4	Atherosclerosis 01/2020 - 01/2004
4	Heart Arrest (Cardiac Arrest) 01/2013 - 05/2007
3	Acute Kidney Injury (Acute Renal Failure) 07/2022 - 01/2018
3	Mitral Valve Insufficiency (Mitral Regurgitation) 06/2021 - 01/2018
3	Hyperemia 03/2021 - 01/2019
3	Transient Ischemic Attack 03/2020 - 03/2013
3	False Aneurysm (Pseudoaneurysm) 01/2019 - 01/2014
3	Hematoma 01/2019 - 08/2010
3	Frailty 09/2018 - 03/2017
3	Atrial Fibrillation 01/2012 - 11/2010
2	No-Reflow Phenomenon 02/2022 - 01/2014

Drug/Important Bio-Agent (IBA)

33	Glycoproteins (Glycoprotein)IBA 10/2021 - 05/2008
24	Abciximab (ReoPro)FDA Link 01/2015 - 01/2002
22	omega-Chloroacetophenone (Mace)IBA 01/2019 - 09/2002
20	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2022 - 02/2005
20	MetalsIBA 10/2019 - 03/2008
18	bivalirudin (Angiomax)FDA Link 01/2019 - 05/2008
17	TicagrelorIBA 09/2022 - 01/2014
17	Heparin (Liquaemin)FDA LinkGeneric 02/2015 - 11/2005
15	Everolimus FDA Link 07/2019 - 03/2008
12	Clopidogrel (Plavix)FDA Link 09/2021 - 02/2005
12	Platelet Membrane Glycoprotein IIbIBA 01/2014 - 01/2003
10	Prasugrel Hydrochloride FDA Link 09/2021 - 04/2011
9	Pharmaceutical PreparationsIBA 10/2020 - 03/2009
7	PolymersIBA 01/2020 - 11/2010
7	TroponinIBA 01/2017 - 03/2003
6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2015 - 01/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2014 - 09/2004
6	Paclitaxel (Taxol)FDA LinkGeneric 11/2013 - 05/2009
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2022 - 01/2020
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 01/2002
5	LipidsIBA 01/2021 - 01/2015
4	MB Form Creatine KinaseIBA 07/2015 - 03/2013
4	Thrombin FDA Link 01/2014 - 10/2009
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2013 - 08/2006
3	Adenosine (Adenocard)FDA LinkGeneric 03/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2009
3	Sirolimus (Rapamycin)FDA Link 03/2018 - 09/2016
3	Creatine Kinase (Creatine Phosphokinase)IBA 07/2015 - 08/2012
3	Phenobarbital (Luminal)FDA Link 03/2014 - 05/2012
3	AnticoagulantsIBA 01/2013 - 07/2011
3	AntithrombinsIBA 06/2011 - 05/2008
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011 - 09/2004
3	C-Reactive ProteinIBA 09/2008 - 09/2004

Therapy/Procedure

154	Percutaneous Coronary Intervention 09/2022 - 01/2002
105	Stents 02/2022 - 11/2002
59	Therapeutics 03/2022 - 01/2002
28	Transcatheter Aortic Valve Replacement 01/2022 - 08/2009
24	Drug-Eluting Stents 03/2022 - 03/2008
20	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 06/2022 - 02/2008
13	Thrombectomy 01/2019 - 12/2004
8	Blood Transfusion (Blood Transfusions) 04/2020 - 11/2010
8	Drug Therapy (Chemotherapy) 01/2015 - 01/2005
7	Catheters 01/2016 - 01/2003
5	Punctures 02/2022 - 08/2010
5	Length of Stay 01/2019 - 02/2009
5	Conservative Treatment 01/2015 - 06/2007
5	Time-to-Treatment 01/2014 - 03/2008
5	Thrombolytic Therapy 08/2013 - 01/2003
4	Secondary Prevention 01/2021 - 03/2013
4	Surgical Amputation (Amputations) 03/2020 - 02/2008
4	Denervation 01/2018 - 01/2016
4	Myocardial Revascularization 01/2017 - 04/2008
4	Carotid Endarterectomy 01/2015 - 01/2003
3	Treatment Delay 08/2021 - 01/2015
3	Heart-Assist Devices 07/2021 - 01/2020
3	Heart Transplantation (Grafting, Heart) 01/2020 - 05/2007
3	Contraindications 02/2014 - 09/2004